Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Rapamycin is considered to be one of the most promising healthspan-promoting interventions for its role in slowing down the formation of senescent cells through its inhibition of the mTOR pathway.
Rapamycin is considered to be one of the most promising healthspan-promoting interventions for its role in slowing down the formation of senescent cells through its inhibition of the mTOR pathway.